Francesca Jackson‐Spence

476 total citations · 1 hit paper
29 papers, 235 citations indexed

About

Francesca Jackson‐Spence is a scholar working on Surgery, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Francesca Jackson‐Spence has authored 29 papers receiving a total of 235 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Surgery, 14 papers in Oncology and 9 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Francesca Jackson‐Spence's work include Bladder and Urothelial Cancer Treatments (15 papers), Urinary and Genital Oncology Studies (8 papers) and Renal cell carcinoma treatment (7 papers). Francesca Jackson‐Spence is often cited by papers focused on Bladder and Urothelial Cancer Treatments (15 papers), Urinary and Genital Oncology Studies (8 papers) and Renal cell carcinoma treatment (7 papers). Francesca Jackson‐Spence collaborates with scholars based in United Kingdom, Spain and Netherlands. Francesca Jackson‐Spence's co-authors include Bernadett Szabados, Thomas Powles, Matthew R. Young, Felicity Evison, Axel Bex, Elizabeth Day, Luis Beltrán, Adnan Sharif, Helen Parsons and John Parkin and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and Cancer.

In The Last Decade

Francesca Jackson‐Spence

27 papers receiving 234 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Renal cell carcinoma

2024 69 citations Matthew R. Young, Francesca Jackson‐Spence et al. The Lancet profile →

Peers

Francesca Jackson‐Spence

SURGE

PRM

ONCOL

Edward Schervish United States

Pernilla Sundqvist Sweden

Ana Medina Spain

M. Elizabeth H. Hammond United States

Fady Ghali United States

Facundo Davaro United States

Nicholas T. Karanikolas United States

Mehran Afshar United Kingdom

Paimaun Zakikhani United Kingdom

Enrico Prosperi Italy

Edward Schervish United States

Francesca Jackson‐Spence

204 ×1.7

SURGE

114 ×1.4

PRM

24 ×0.4

ONCOL

95 ×1.8

19 ×0.5

Citations per year, relative to Francesca Jackson‐Spence Francesca Jackson‐Spence (= 1×) peers Edward Schervish

Countries citing papers authored by Francesca Jackson‐Spence

Since Specialization

Citations

This map shows the geographic impact of Francesca Jackson‐Spence's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Francesca Jackson‐Spence with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Francesca Jackson‐Spence more than expected).

Fields of papers citing papers by Francesca Jackson‐Spence

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Francesca Jackson‐Spence. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Francesca Jackson‐Spence. The network helps show where Francesca Jackson‐Spence may publish in the future.

Co-authorship network of co-authors of Francesca Jackson‐Spence

This figure shows the co-authorship network connecting the top 25 collaborators of Francesca Jackson‐Spence. A scholar is included among the top collaborators of Francesca Jackson‐Spence based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Francesca Jackson‐Spence. Francesca Jackson‐Spence is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Jackson‐Spence, Francesca, et al.. (2025). Established and emerging biomarkers approaches in urothelial carcinoma. Expert Review of Anticancer Therapy. 25(11). 1235–1241. 2 indexed citations

Young, Matthew R., Francesca Jackson‐Spence, Luis Beltrán, et al.. (2024). Renal cell carcinoma. The Lancet. 404(10451). 476–491. 69 indexed citations breakdown →

Jackson‐Spence, Francesca, Christopher C.T. Sng, Lucy Flanders, et al.. (2024). Systemic therapies and primary tumour downsizing in renal cell carcinoma: a real-world comparison of anti-angiogenic and immune checkpoint inhibition regimens. World Journal of Urology. 42(1). 442–442. 2 indexed citations

Szabados, Bernadett, et al.. (2024). NLR Outperforms Low Hemoglobin and High Platelet Count as Predictive and Prognostic Biomarker in Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors. Clinical Genitourinary Cancer. 22(3). 102072–102072. 5 indexed citations

Szabados, Bernadett, Zoe J. Assaf, Francesca Jackson‐Spence, et al.. (2024). Predictive value of dynamic changes in ctDNA and baseline biomarkers with neoadjuvant atezolizumab in operable urothelial carcinoma in the ABACUS trial.. Journal of Clinical Oncology. 42(4_suppl). 534–534. 2 indexed citations

Young, Matthew R., et al.. (2024). Upper Tract Urothelial Carcinoma (UTUC): Prevalence, Impact and Management Challenge. Cancer Management and Research. Volume 16. 467–475. 3 indexed citations

Young, Matthew R., et al.. (2024). Is HER2 the New NECTIN4 in Advanced Urothelial Cancer?. European Urology Focus. 10(2). 219–221.

Jackson‐Spence, Francesca, Javier Puente, Javier Molina‐Cerrillo, et al.. (2023). 2408TiP DISCUS: A randomised phase II study of 3 vs 6 cycles of chemotherapy followed by maintenance avelumab in advanced urothelial cancer - Wearable devices and circulating biomarkers assessing quality of life and surrogate efficacy endpoints. Annals of Oncology. 34. S1224–S1225. 1 indexed citations

Jackson‐Spence, Francesca, Matthew R. Young, Christopher J. Sweeney, & Thomas Powles. (2023). Top advances of the year: Genitourinary cancer. Cancer. 129(17). 2603–2609. 3 indexed citations

10.

Meerveld-Eggink, A., Francesca Jackson‐Spence, Kathrine S Rallis, et al.. (2023). Baseline and Dynamic Changes in Hemoglobin Levels Predict Treatment Response and Prognosis in Metastatic Renal Cell Carcinoma: A Multicenter Retrospective Study. Clinical Genitourinary Cancer. 21(4). e242–e251. 2 indexed citations

11.

Yang, Yao‐Hsu, Cankut Çubuk, Romain Banchereau, et al.. (2023). 2393P Ephrin signalling mediates resistance to programmed death ligand 1 (PD-L1) inhibition in urothelial carcinoma (UC). Annals of Oncology. 34. S1218–S1218.

12.

Jackson‐Spence, Francesca, et al.. (2022). Avelumab in locally advanced or metastatic urothelial carcinoma. Expert Review of Anticancer Therapy. 22(2). 135–140. 3 indexed citations

13.

Jackson‐Spence, Francesca, et al.. (2022). The role of modern immunotherapy in metastatic urothelial cancer: mini review. Journal of Cancer Metastasis and Treatment. 8. 40–40. 1 indexed citations

14.

Szabados, Bernadett, et al.. (2021). Immune Checkpoint Inhibitors in Front-line Therapy for Urothelial Cancer. European Urology Oncology. 4(6). 943–947. 12 indexed citations

15.

Lam, Jie Min, et al.. (2020). Cytoreductive nephrectomy in metastatic renal cell carcinoma: outcome of patients treated with a multidisciplinary, algorithm-driven approach. World Journal of Urology. 38(12). 3199–3205. 7 indexed citations

16.

Arshad, Adam, Francesca Jackson‐Spence, & Adnan Sharif. (2019). Development and evaluation of dedicated low clearance transplant clinics for patients with failing kidney transplants. Journal of Renal Care. 45(1). 51–58. 6 indexed citations

17.

Jackson‐Spence, Francesca, et al.. (2018). Mortality risk after cancer diagnosis in kidney transplant recipients: the limitations of analyzing hospital administration data alone. Cancer Medicine. 7(3). 931–939. 6 indexed citations

18.

Jackson‐Spence, Francesca, Jemma Mytton, Felicity Evison, et al.. (2017). Pre‐existing diabetes is a risk factor for increased rates of cellular rejection after kidney transplantation: an observational cohort study. Diabetic Medicine. 34(8). 1067–1073. 7 indexed citations

19.

Afshar, Mehran, Henry Goodfellow, Francesca Jackson‐Spence, et al.. (2017). Centralisation of radical cystectomies for bladder cancer in England, a decade on from the ‘Improving Outcomes Guidance’: the case for super centralisation. British Journal of Urology. 121(2). 217–224. 47 indexed citations

20.

Jackson‐Spence, Francesca, et al.. (2016). Balancing risks for older kidney transplant recipients in the contemporary era: A single-centre observational study. European Geriatric Medicine. 8(1). 42–47. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact